Probiotic composition and application thereof in resisting helicobacter pylori

Microcapsules were prepared by endogenous emulsification, which solved the drug resistance and flora imbalance of antibiotics in the treatment of Helicobacter pylori, significantly inhibiting the growth of Helicobacter pylori and urease activity, reducing recurrence rate.

CN119074763AActive Publication Date: 2024-12-06GUANGDONG YIYUANBAO BIOTECHNOLOGY CO LTD
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202411223973.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-12-06
Estimated Expiration
2044-09-03

AI Technical Summary

Technical Problem

Antibiotics have drug resistance problems, adverse reactions and dysbiosis in the treatment of Helicobacter pylori, resulting in poor treatment effect and high recurrence rate.

Method used

采用内源乳化法将凝结魏茨曼氏菌、鼠李糖乳杆菌和格氏乳杆菌等益生菌包裹成微胶囊,并加入3-吲哚-乳酸或纳米硒化钼,通过滴加和搅拌形成油相水相乳化体系,经过冷冻干燥制备益生菌组合物,显著抑制幽门螺旋杆菌的生长和脲酶活性。

Benefits of technology

Effectively protect probiotics, enhance the balance of intestinal flora, significantly inhibit the growth of Helicobacter pylori and urease activity, reduce the rate of infection recurrence, and have a significant inhibitory effect on urease.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a probiotic composition and an application of the probiotic composition in resisting helicobacter pylori. According to the preparation method disclosed by the invention, the probiotic microcapsule is prepared from Witzia ciliaris powder, Lactobacillus rhamnosus powder, Lactobacillus gasseri powder, nano molybdenum selenide and / or 3-indole-lactic acid through an endogenous emulsification method. Compared with the prior art, the preparation method has the advantages that the probiotics can be effectively wrapped in the microcapsule by adopting an endogenous emulsification method, so that the probiotics are protected from being influenced by the external environment; the particle size and form of the microcapsule can be controlled, so that the microcapsule has better stability and release characteristic. Moreover, the probiotic composition disclosed by the invention has a remarkable inhibition effect on urease.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of probiotics, and in particular to a probiotic composition and application thereof in resisting Helicobacter pylori. Background Art

[0002] Helicobacter pylori is a Gram-negative bacterium that mainly lives in the human stomach and duodenum. At present, antibiotics play a key role in the treatment of Helicobacter pylori. The treatment of Helicobacter pylori usually uses a combination of proton pump inhibitors, bismuth agents and two antibiotics. Common combinations include amoxicillin + clarithromycin. Antibiotics mainly exert their bactericidal effects by interfering with the cell wall synthesis and protein synthesis of Helicobacter pylori. However, there are also disadvantages in the treatment of Helicobacter pylori with antibiotics. The first is the problem of drug resistance. With widespread use, the resistance rate of Helicobacter pylori to some antibiotics has gradually increased. The emergence of drug-resistant strains increases the risk of treatment failure. Drug resistance is mainly due to gene mutations, irrational use and gene transmission. The second is adverse reactions, which may cause gastrointestinal discomfort, allergic reactions, abnormal liver function, etc., affecting patients' treatment compliance and even leading to treatment interruption. The third is dysbacteriosis. Long-term or large-scale use of antibiotics will destroy the balance of normal flora in the human intestine, cause symptoms such as diarrhea, increase the risk of infection with other pathogens, and may also affect the human immune system and metabolic function.

[0003] Probiotics may play an auxiliary therapeutic role by regulating intestinal flora, enhancing intestinal mucosal barrier function, inhibiting the growth and adhesion of Helicobacter pylori, etc. Helicobacter pylori infection is prone to relapse after treatment. Probiotics can help maintain the balance of intestinal flora and enhance the body's immunity, thereby reducing the recurrence rate of Helicobacter pylori infection.

[0004] CN109662321A discloses a composite probiotic microcapsule and a preparation method thereof, wherein the core material comprises composite probiotics (bifidobacterium, Lactobacillus plantarum, Lactobacillus casei), and the wall material comprises konjac glucomannan and sodium alginate, and the composite wall material can effectively improve the protective effect on probiotics. CN115006432A discloses a composite probiotic microcapsule and a preparation method thereof, wherein the invention uses an endogenous emulsification method, with composite probiotics comprising bifidobacterium, Lactobacillus plantarum, and Lactobacillus casei as the core material, and konjac glucomannan and sodium alginate as the wall material to prepare probiotic microcapsules, and the method is simple to operate, low in cost, high in embedding rate, and high in cost performance, and the composite wall material can effectively improve the protective effect on probiotics. Summary of the invention

[0005] The technical problem to be solved by the present invention is to provide an endogenous emulsification method to prepare probiotics (coagulated Weizmannella powder, Lactobacillus rhamnosus powder, Lactobacillus gasseri powder) into probiotic microcapsules, thereby protecting the probiotics from the influence of the external environment; and at the same time having a significant inhibitory effect on urease.

[0006] To achieve the above object, the present invention provides a method for preparing a probiotic composition, comprising the following steps:

[0007] S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of coagulated Weizmannella powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, and 6-12 g of nano molybdenum selenide to 150-300 mL of sterile water, and stir and mix for 20-50 min to obtain an aqueous phase;

[0008] S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase;

[0009] S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

[0010] A preferred technical solution is a method for preparing the probiotic composition, comprising the following steps:

[0011] S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of Weizmannella coagulans powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, and 6-12 g of 3-indole-lactic acid to 150-300 mL of sterile water, and stir for 20-50 min to obtain an aqueous phase;

[0012] S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase;

[0013] S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

[0014] The most preferred technical solution is a method for preparing the probiotic composition, comprising the following steps:

[0015] S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of coagulated Weizmannella powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, 3-6 g of nano-molybdenum selenide, and 3-6 g of 3-indole-lactic acid to 150-300 mL of sterile water, and stir for 20-50 min to obtain an aqueous phase;

[0016] S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase;

[0017] S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

[0018] Preferably, the coagulant Weizmannella powder is selected from Weizmannella coagulata BC99; the Lactobacillus rhamnosus powder is selected from Lactobacillus rhamnosus LRa05; and the Lactobacillus gasseri powder is selected from Lactobacillus gasseri LG08.

[0019] Weizmannella coagulans BC99 is resistant to high temperature and high pressure and can remain active in high temperature environments. It can compete with Helicobacter pylori for living space and nutrients in the gastrointestinal tract, thereby reducing the colonization of Helicobacter pylori. For example, on the surface of the intestinal mucosa, Weizmannella coagulans occupies binding sites, making it difficult for Helicobacter pylori to attach, reducing the chance of infection. On the other hand, Weizmannella coagulans BC99 may secrete some metabolites with antibacterial activity, which inhibit the growth of Helicobacter pylori. These metabolites may include organic acids, bacteriocins, etc., which can destroy the cell membrane structure of Helicobacter pylori or interfere with its metabolic process, inhibiting its growth and reproduction.

[0020] Lactobacillus rhamnosus LRa05 can stimulate the intestinal immune system, promote the secretion of immune factors, and enhance the barrier function of the intestinal mucosa, thereby reducing the invasion of Helicobacter pylori. On the other hand, Lactobacillus rhamnosus LRa05 helps maintain the dominant position of beneficial bacteria in the intestine and improve the intestinal microecological environment by regulating the activity of immune cells. Healthy intestinal flora can inhibit the growth of Helicobacter pylori and prevent its over-reproduction. Not only that, it can also compete with Helicobacter pylori for adhesion sites on the intestinal mucosa, preventing Helicobacter pylori from attaching, thereby reducing the risk of infection.

[0021] Lactobacillus gasseri LG08 can produce some antimicrobial peptides or other antimicrobial substances that directly inhibit the growth of Helicobacter pylori. These antimicrobial substances are highly specific and active, and can specifically attack Helicobacter pylori, while having little effect on normal cells and beneficial bacteria in the human body.

[0022] Endogenous emulsification is a method for preparing microcapsules. Its basic principle is to use two or more phases in the system to form microcapsules through processes such as phase separation or coagulation. In the process of preparing probiotic microcapsules, the endogenous emulsification method usually disperses the probiotics in one phase of the water phase or oil phase, and then mixes it with the other phase to form an emulsified system by stirring or other means. In the emulsified system, the probiotics are encapsulated in tiny droplets, which can be further processed, such as solidification, drying, etc., to form microcapsules. The endogenous emulsification method can effectively encapsulate the probiotics inside the microcapsule and protect the probiotics from the influence of the external environment, such as gastric acid, bile, etc. The particle size and morphology of the microcapsules can be controlled, so that they have better stability and release characteristics.

[0023] Studies have shown that 3-indole-lactic acid can increase the richness and diversity of intestinal flora, reduce the relative abundance of potential pathogens, and promote the growth of beneficial bacteria such as lactobacilli. The inventors found that 3-indole-lactic acid can also effectively inhibit the urease activity of Helicobacter pylori, thereby hindering the colonization of bacteria in the gastric epithelium or mucus layer.

[0024] Preferably, the preparation method of the nano molybdenum selenide is as follows:

[0025] Disperse 1-3g of sodium molybdate in 400-600mL of ethanol-water solution and stir for 10-20min; add 40-60mL of hydrazine-water solution containing 1-2g of selenium powder, stir for 20-40min, heat in a sealed container at 180-220°C for 8-12h, and cool naturally to room temperature; centrifuge at 15000-21000rpm for 5-15min, remove the supernatant and take the precipitate, dry and grind to obtain nano-molybdenum selenide. The volume ratio of ethanol to water in the ethanol-water solution is 1:1. The concentration of the hydrazine-water solution is 60wt%.

[0026] Mo in Nano MoSe 4+ Oxidation to form MoO4 2- , which can interfere with the normal metabolic process of Helicobacter pylori and inhibit its growth and reproduction. Selenium in nano-molybdenum selenide can promote the growth of beneficial bacteria while inhibiting the growth of Helicobacter pylori. Importantly, compared with antibiotics, nano-molybdenum selenide can maintain the balance of intestinal flora and have less adverse effects on the community structure of intestinal flora.

[0027] Preferably, freeze-drying parameters are: set the pre-freezing temperature to -20°C, keep the sample temperature at -20°C for 1.5 hours, set the sublimation temperature to 12°C, the decomposition temperature to 34°C, the vacuum degree to 25 Pa, and dry for 24 hours.

[0028] Beneficial effects of the present invention:

[0029] Compared with the prior art, the present invention adopts the endogenous emulsification method to effectively encapsulate the probiotics inside the microcapsule, protecting the probiotics from the influence of the external environment. The particle size and morphology of the microcapsule can be controlled to have good stability and release characteristics. The probiotic composition of the present invention has a significant inhibitory effect on urease. DETAILED DESCRIPTION

[0030] Parameters for specific chemical substances used, sources.

[0031] The coagulated Weizmannella powder, in the example, is coagulated Weizmannella BC99, with a specification of 300 billion CFU / g, and is sourced from Weikang Probiotics (Suzhou) Co., Ltd.

[0032] Lactobacillus rhamnosus powder, in the example, Lactobacillus rhamnosus LRa05, with a specification of 600 billion CFU / g, comes from Weikang Probiotics (Suzhou) Co., Ltd.

[0033] Lactobacillus gasseri powder, in the example, is Lactobacillus gasseri LG08, with a specification of 500 billion CFU / g, and is sourced from Weikang Probiotics (Suzhou) Co., Ltd.

[0034] Example 1

[0035] A method for preparing a probiotic composition is as follows:

[0036] 4 g of sodium alginate, 16 g of calcium carbonate, 5 g of Weizmannella coagulans powder, 5 g of Lactobacillus rhamnosus powder, 5 g of Lactobacillus gasseri powder, and 10 g of nano-molybdenum selenide were added to 200 mL of sterile water and stirred for 30 min to obtain an aqueous phase;

[0037] Add 6 mL of Tween 80 into 600 mL of soybean oil and stir for 30 min to obtain the oil phase;

[0038] The aqueous phase was added dropwise to the oil phase at a volume ratio of 1:3. After the addition was completed, the mixture was stirred at 200 rpm for 15 min; 2 mL of glacial acetic acid was added and stirred at 200 rpm for 30 min; 600 mL of 0.1 mol / L pH 5.5 acetate buffer solution was added and stirred at 50 rpm for 5 min; the mixture was allowed to stand for 2 h, the lower precipitate was removed, and the mixture was washed with anhydrous ethanol 3 times, each time with 300 mL of anhydrous ethanol, and then washed with sterile water 3 times, each time with 300 mL of sterile water; the mixture was freeze-dried to obtain a probiotic composition. The freeze-drying parameters were as follows: the pre-freezing temperature was set to -20 °C, the sample temperature was kept at -20 °C for 1.5 h, the sublimation temperature was set to 12 °C, the decomposition temperature was set to 34 °C, the vacuum degree was 25 Pa, and the mixture was dried for 24 h.

[0039] The preparation method of the nano molybdenum selenide is as follows:

[0040] 2.1 g of sodium molybdate was dispersed in 500 mL of ethanol aqueous solution (volume ratio 1:1), and stirred for 15 min; 50 mL of hydrazine aqueous solution (containing 60 wt% hydrazine) containing 1.6 g of selenium powder was added, and after stirring for 30 min, it was transferred to a stainless steel autoclave with a polytetrafluoroethylene liner, heated at 200° C. for 10 h, and naturally cooled to room temperature; centrifuged at 20,000 rpm for 10 min, the supernatant was removed, and the precipitate was taken out, dried, and ground to obtain nano molybdenum selenide.

[0041] Example 2

[0042] A method for preparing a probiotic composition is as follows:

[0043] 4 g of sodium alginate, 16 g of calcium carbonate, 5 g of Weizmannella coagulans powder, 5 g of Lactobacillus rhamnosus powder, 5 g of Lactobacillus gasseri powder, and 10 g of 3-indole-lactic acid were added to 200 mL of sterile water and stirred for 30 min to obtain an aqueous phase;

[0044] Add 6 mL of Tween 80 into 600 mL of soybean oil and stir for 30 min to obtain the oil phase;

[0045] The aqueous phase was added dropwise to the oil phase at a volume ratio of 1:3. After the addition was completed, the mixture was stirred at 200 rpm for 15 min; 2 mL of glacial acetic acid was added and stirred at 200 rpm for 30 min; 600 mL of 0.1 mol / L pH 5.5 acetate buffer solution was added and stirred at 50 rpm for 5 min; the mixture was allowed to stand for 2 h, the lower precipitate was removed, and the mixture was washed with anhydrous ethanol 3 times, each time with 300 mL of anhydrous ethanol, and then washed with sterile water 3 times, each time with 300 mL of sterile water; the mixture was freeze-dried to obtain a probiotic composition. The freeze-drying parameters were as follows: the pre-freezing temperature was set to -20 °C, the sample temperature was kept at -20 °C for 1.5 h, the sublimation temperature was set to 12 °C, the decomposition temperature was set to 34 °C, the vacuum degree was 25 Pa, and the mixture was dried for 24 h.

[0046] Example 3

[0047] A method for preparing a probiotic composition is as follows:

[0048] 4 g of sodium alginate, 16 g of calcium carbonate, 5 g of Weizmannella coagulans powder, 5 g of Lactobacillus rhamnosus powder, 5 g of Lactobacillus gasseri powder, 5 g of nano-molybdenum selenide, and 5 g of 3-indole-lactic acid were added to 200 mL of sterile water and stirred for 30 min to obtain an aqueous phase;

[0049] Add 6 mL of Tween 80 into 600 mL of soybean oil and stir for 30 min to obtain the oil phase;

[0050] The aqueous phase was added dropwise to the oil phase at a volume ratio of 1:3. After the addition was completed, the mixture was stirred at 200 rpm for 15 min; 2 mL of glacial acetic acid was added and stirred at 200 rpm for 30 min; 600 mL of 0.1 mol / L pH 5.5 acetate buffer solution was added and stirred at 50 rpm for 5 min; the mixture was allowed to stand for 2 h, the lower precipitate was removed, and the mixture was washed with anhydrous ethanol 3 times, each time with 300 mL of anhydrous ethanol, and then washed with sterile water 3 times, each time with 300 mL of sterile water; the mixture was freeze-dried to obtain a probiotic composition. The freeze-drying parameters were as follows: the pre-freezing temperature was set to -20 °C, the sample temperature was kept at -20 °C for 1.5 h, the sublimation temperature was set to 12 °C, the decomposition temperature was set to 34 °C, the vacuum degree was 25 Pa, and the mixture was dried for 24 h.

[0051] The preparation method of the nano molybdenum selenide is as follows:

[0052] 2.1 g of sodium molybdate was dispersed in 500 mL of ethanol aqueous solution (volume ratio 1:1), and stirred for 15 min; 50 mL of hydrazine aqueous solution (containing 60 wt% hydrazine) containing 1.6 g of selenium powder was added, and after stirring for 30 min, it was transferred to a stainless steel autoclave with a polytetrafluoroethylene liner, heated at 200° C. for 10 h, and naturally cooled to room temperature; centrifuged at 20,000 rpm for 10 min, the supernatant was removed, and the precipitate was taken out, dried, and ground to obtain nano molybdenum selenide.

[0053] Comparative Example 1

[0054] A method for preparing a probiotic composition is as follows:

[0055] Add 4 g of sodium alginate, 16 g of calcium carbonate, 5 g of Weizmannella coagulans powder, 5 g of Lactobacillus rhamnosus powder, and 5 g of Lactobacillus gasseri powder into 200 mL of sterile water and stir for 30 min to obtain an aqueous phase;

[0056] Add 6 mL of Tween 80 into 600 mL of soybean oil and stir for 30 min to obtain the oil phase;

[0057] The aqueous phase was added to the oil phase at a volume ratio of 1:3, and the mixture was stirred for 15 minutes after the addition was completed; 2 mL of glacial acetic acid was added and stirred for 30 minutes; 600 mL of 0.1 mol / L pH 5.5 acetate buffer solution was added and stirred at 50 rpm for 5 minutes; the mixture was allowed to stand for 2 hours, the lower precipitate was removed, and the mixture was washed with anhydrous ethanol 3 times, each time with 300 mL of anhydrous ethanol, and then washed with sterile water 3 times, each time with 300 mL of sterile water; the mixture was freeze-dried to obtain a probiotic composition. The freeze-drying parameters were: the pre-freezing temperature was set to -20°C, the sample temperature was kept at -20°C for 1.5 hours, the sublimation temperature was set to 12°C, the desorption temperature was set to 34°C, the vacuum degree was 25 Pa, and the mixture was dried for 24 hours.

[0058] Test Example 1

[0059] Helicobacter pylori antibacterial test

[0060] (1) Preparation of bacterial solution: Helicobacter pylori was cultured to the logarithmic phase, 5 mL of bacterial solution was taken, centrifuged at 5000 g for 5 min, and the bacteria were resuspended in TSB medium and the concentration of the bacterial solution was adjusted to 1×10 6 CFU / mL;

[0061] (2) Take a 96-well plate, add 100 μL of the bacterial solution in step (1) above, 95 μL of TSB culture medium, and 5 μL of the test solution to each well, and add 5 μL of dimethyl sulfoxide as a blank control. Set up 3 replicates for each treatment. Place the 96-well plate at 37°C and shake at 150 rpm for 48 hours; the preparation method of the test solution is: resuspend 1 g of the probiotic composition of the embodiment and the control example with 100 mL of sterile water.

[0062] (3) Based on OD 600 The value reflects the concentration of bacterial solution, and the inhibition rate (%) is calculated according to the following formula: (OD 600 Control bacterial solution-OD 600 Treated bacterial solution) / OD 600 Control bacterial solution × 100%.

[0063] Table 1

[0064] Antibacterial rate (%) Example 1 39.8 Example 2 43.9 Example 3 49.2 Comparative Example 1 28.7

[0065] It can be seen from the above table that the probiotic composition of Example 1-2 has a significantly better inhibitory effect on Helicobacter pylori than that of Control Example 1. Obviously, adding 3-indole-lactic acid or nano-molybdenum selenide in the process of preparing probiotic microcapsules by the endogenous emulsification method can effectively improve the inhibitory effect of probiotic microcapsules on Helicobacter pylori. The possible reason is that 3-indole-lactic acid has a certain fat solubility and may penetrate into the periplasmic space between the inner and outer membranes through the surface protein of Helicobacter pylori membrane, resulting in damage to the integrity of the outer membrane and leakage of intracellular substances, thereby achieving the inhibition of Helicobacter pylori. Mo in nano-molybdenum selenide 4+ Oxidation to form MoO4 2- , which can interfere with the normal metabolic process of Helicobacter pylori and inhibit its growth and reproduction.

[0066] Test Example 2

[0067] Determination of the Inhibition of Helicobacter pylori Urease Activity

[0068] Before the experiment, turn on the ultraviolet light in the clean bench for more than 30 minutes, and then turn on the fan for 5 minutes before starting the experimental operation. 8 CFU / mL. Take 2mL of bacterial solution and add it to a screw-cap tube, add the test solution respectively, vortex and shake for 5 minutes, and culture at 37℃ microaerophilic (85% N2, 10% CO2, 5% O2) for 6 hours. Then take 100μL of each group of solutions into a 96-well plate, and then add an equal amount of urea-phenol red reagent to induce a biochemical reaction. After reacting for 30 minutes, put it into an ELISA reader and measure its absorbance at 550nm. Perform 3 parallel experiments for each experimental group.

[0069] Urease inhibition rate (%) = (absorbance of control group - absorbance of experimental group) / absorbance of control group × 100%

[0070] Table 2

[0071] Urease inhibition rate (%) Example 1 45.9 Example 2 60.1 Example 3 69.3 Comparative Example 1 34.8

[0072] Urease is one of the important virulence factors of Helicobacter pylori. Helicobacter pylori can produce a large amount of urease, which can decompose urea in the stomach and produce ammonia, thereby neutralizing gastric acid and creating a suitable microenvironment for the survival of bacteria in the stomach. In addition, urease is also involved in the adhesion and colonization process of Helicobacter pylori.

[0073] As can be seen from the above table, the inhibitory effect of the probiotic composition of Example 2 on urease is significantly better than that of Example 1 and Comparative Example 1. Obviously, the inhibition rate of urease by adding 3-indole-lactic acid in the process of preparing probiotic microcapsules by the endogenous emulsification method is significantly better than that by adding nano-molybdenum selenide or not adding. The possible reason is that 3-indole-lactic acid can cause the acidic functional groups (such as phosphate groups) on the cell wall and cell membrane of Helicobacter pylori to be deprotonated, increasing the negative charge on the bacterial surface. This will affect the stability of the cell membrane, reduce the interaction between the cell membrane and the cell wall, and thus interfere with the normal function of urease. It may also be that 3-indole-lactic acid can interfere with the metabolic pathway of Helicobacter pylori, affect the synthesis or regulation of urease, and lead to a decrease in urease activity.

Claims

1. A method for preparing a probiotic composition, characterized in that: The following steps are involved: S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of coagulated Weizmannella powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, and 6-12 g of nano molybdenum selenide to 150-300 mL of sterile water, and stir and mix for 20-50 min to obtain an aqueous phase; S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase; S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

2. A method for preparing a probiotic composition, characterized in that: The following steps are involved: S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of Weizmannella coagulans powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, and 6-12 g of 3-indole-lactic acid to 150-300 mL of sterile water, and stir for 20-50 min to obtain an aqueous phase; S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase; S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

3. A method for preparing a probiotic composition, characterized in that: The following steps are involved: S1: Add 3-6 g of sodium alginate, 10-20 g of calcium carbonate, 3-6 g of coagulated Weizmannella powder, 3-6 g of Lactobacillus rhamnosus powder, 3-6 g of Lactobacillus gasseri powder, 3-6 g of nano-molybdenum selenide, and 3-6 g of 3-indole-lactic acid to 150-300 mL of sterile water, and stir for 20-50 min to obtain an aqueous phase; S2: Add 4-8 mL of Tween 80 to 400-800 mL of soybean oil and stir for 20-40 min to obtain an oil phase; S3: adding the aqueous phase to the oil phase at a volume ratio of 1:2-4, stirring and mixing for 10-25 minutes after the addition is completed; adding 1-3 mL of glacial acetic acid and stirring for 20-40 minutes; adding 400-600 mL of 0.1-0.2 mol / L pH 5.5 acetate buffer solution, stirring at a speed of 20-60 rpm for 3-6 minutes; standing for 1-3 hours, removing the lower precipitate, washing with anhydrous ethanol and sterile water respectively; freeze-drying to obtain a probiotic composition.

4. The method for preparing the probiotic composition according to claim 1, 2 or 3, characterized in that: The coagulant Weizmannella powder is selected from coagulant Weizmannella BC99; the Lactobacillus rhamnosus powder is selected from Lactobacillus rhamnosus LRa05; and the Lactobacillus gasseri powder is selected from Lactobacillus gasseri LG08.

5. The method for preparing the probiotic composition according to claim 1 or 3, characterized in that: The preparation method of the nano molybdenum selenide is as follows: 1-3g of sodium molybdate is dispersed in 400-600mL of ethanol aqueous solution and stirred for 10-20min; 40-60mL of hydrazine aqueous solution containing 1-2g of selenium powder is added, stirred for 20-40min, and then sealed and heated at 180-220°C for 8-12h, and naturally cooled to room temperature; centrifuged at 15000-21000rpm for 5-15min, the supernatant is removed to obtain the precipitate, and the precipitate is dried and ground to obtain the nano molybdenum selenide.

6. The method for preparing the probiotic composition according to claim 5, characterized in that: The volume ratio of ethanol to water in the ethanol aqueous solution is 1:

1.

7. The method for preparing the probiotic composition according to claim 5, characterized in that: The concentration of the hydrazine aqueous solution is 60 wt %.

8. The method for preparing the probiotic composition according to claim 1, characterized in that: The freeze-drying parameters are as follows: set the pre-freezing temperature to -20°C, keep the sample temperature at -20°C for 1.5 hours, set the sublimation temperature to 12°C, the decomposition temperature to 34°C, the vacuum degree to 25 Pa, and dry for 24 hours.

9. A probiotic composition, characterized in that: Prepared by the method according to any one of claims 1 to 8.

10. Use of the probiotic composition according to claim 9 in combating Helicobacter pylori.

Citation Information

Patent Citations

  • Probiotic double-layer microcapsule and preparation method thereof

    CN109619593A

  • Composite probiotic microcapsule and preparation method thereof

    CN109662321A

  • Helicobacter pylori resistant composition and application thereof

    CN111820407A

  • Compound probiotics for treating helicobacter pylori infection

    CN111956671A

  • Molybdenum diselenide and polyethyleneimine mimic enzyme nanometer material and preparation and application thereof

    CN114159561A